Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Data from Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity
  1. Home
  2. Publications
  3. Supplementary Data from Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity

Supplementary Data from Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity

Authors:
  • JSJacqueline H. Starrett
    Jacqueline H. Starrett
  • EAEric L. Allen
    Eric L. Allen
  • MNMelissa Neal
    Melissa Neal
  • SISamhita Iyer
    Samhita Iyer
  • QYQing Ye
    Qing Ye
  • RHRobert L. Hudkins
    Robert L. Hudkins
  • VDViraj Degaonkar
    Viraj Degaonkar
  • CLChristine Lihou
    Christine Lihou
  • RSRonald V. Swanson
    Ronald V. Swanson
  • VBValentina Boni
    Valentina Boni
  • JFJesús Fuentes-Antrás
    Jesús Fuentes-Antrás
  • CPCedric Pobel
    Cedric Pobel

Open Access
Publisher website
Google Scholar
  • 2 March 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.31443276
Abstract
Supplementary Data file describes the structure and synthesis method for dabogratinib.
Keywords
  • DRUG TARGETS
  • PROTEIN KINASE & PHOSPHATASE DRUG TARGETS
  • GENITOURINARY CANCERS
  • BLADDER CANCER
  • PRECISION MEDICINE
  • SMALL MOLECULE AGENTS
  • KINASE INHIBITORS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.